ConductScience.org, home

Paper1975321

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Lancet, 1990. Cited by 213 papers, by iCite.

Cite this record

ConductScience Library. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Papers, record 1975321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1975321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
PubMed
Journal
Lancet
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
213
iCite
Relative citation ratio, by iCite
7.13
iCite
Revised in PubMed
2017-09-20
PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HeparinMajor topic
Myocardial InfarctionMajor topic
StreptokinaseMajor topic
Thrombolytic TherapyMajor topic
Tissue Plasminogen ActivatorMajor topic
Aged
Aspirin
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Echocardiography
Female
Humans
Male
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00149591The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)Background

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in1974965GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?https://conductscience.org/library/papers/1974965PubMed
Comment in1975887Limitations of serum creatine kinase assay in diagnosis of acute myocardial infarction.https://conductscience.org/library/papers/1975887PubMed

Download CSV of comments and corrections

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.

PMIDTitleJournalYearIn PapersSource
40429386Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature.J Clin Med2025https://conductscience.org/library/papers/40429386PubMed
39600808Bleeding characteristics and mortality outcomes following ST-elevation myocardial infarction thrombolysis: a 5-year analysis in an Asian population.World J Emerg Med2024https://conductscience.org/library/papers/39600808PubMed
37750155A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries.Cureus2023https://conductscience.org/library/papers/37750155PubMed
36046799Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case.J Neurosurg Case Lessons2021https://conductscience.org/library/papers/36046799PubMed
31531077Optimization and High Level Production of Recombinant Synthetic Streptokinase in E. coli Using Response Surface Methodology.Iran J Pharm Res2019https://conductscience.org/library/papers/31531077PubMed
31074337Embedding patient- and public health-oriented research in a national health service: the GISSI experience.J R Soc Med2019https://conductscience.org/library/papers/31074337PubMed
30627739[Therapy of cardiogenic shock : A success story of German cardiology].Herz2019https://conductscience.org/library/papers/30627739PubMed
29581926Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review.Cureus2018https://conductscience.org/library/papers/29581926PubMed
29391934Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen.J Cardiovasc Thorac Res2017https://conductscience.org/library/papers/29391934PubMed
28894481Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century.Breathe (Sheff)2017https://conductscience.org/library/papers/28894481PubMed
28769230THROMBOLYSIS IN MYOCARDIAL INFARCTION.Med J Armed Forces India1995https://conductscience.org/library/papers/28769230PubMed
28209124RNA-seq and metabolomic analyses of Akt1-mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome.BMC Genomics2017https://conductscience.org/library/papers/28209124PubMed
27904506Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials.Arch Med Sci2016https://conductscience.org/library/papers/27904506PubMed
27696935The evolution of recombinant thrombolytics: Current status and future directions.Bioengineered2017https://conductscience.org/library/papers/27696935PubMed
27326056Spontaneous recovery of complete atrioventricular block complicating acute anterior wall ST elevation myocardial infarction.Heart Asia2012https://conductscience.org/library/papers/27326056PubMed
25894475Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.J Thromb Thrombolysis2015https://conductscience.org/library/papers/25894475PubMed
25746841The relationship between grade of ischemia, success of reperfusion, and type of thrombolytic regimen.Med Sci Monit2015https://conductscience.org/library/papers/25746841PubMed
24972265Heparin versus placebo for non-ST elevation acute coronary syndromes.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24972265PubMed
24829715Fibrinolytic Therapy in CCU Instead of Emergency Ward: How It Affects Door to Needle Time?Int J Prev Med2014https://conductscience.org/library/papers/24829715PubMed
24653840Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.ISRN Cardiol2014https://conductscience.org/library/papers/24653840PubMed

See all 121 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNLZ728489PubTator's text mininghttps://conductscience.org/library/genes/728489NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1975321

GET https://conductscience.org/api/papers/v1/1975321/cited_by?page=2